Seizure News and Research

Latest Seizure News and Research

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

4 Aug 2010

Researchers identify new genetic route to treat epilepsy

New research points to a genetic route to understanding and treating epilepsy. Timothy Jegla, an assistant professor of biology at Penn State University, has identified an ancient gene family that plays a role in regulating the excitability of nerves within the brain.

2 Aug 2010

FDA announces approval of vaccines for 2010-2011 US influenza season

The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States.

31 Jul 2010

Chemical compound provides new angle for developing drugs to treat seizures: Study

A chemical compound that boosts the action of a molecule normally produced in the brain may provide the starting point for a new line of therapies for the treatment of epileptic seizures, according to a new study by scientists at The Scripps Research Institute.

30 Jul 2010

U.S. Marshals seize FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices

At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized $346,954.43 worth of FastSize Extender devices and FastSize EQM™ Erectile Quality Monitor devices, as well as component parts used in the manufacture of the FastSize Extender. The FastSize Extender and the FastSize EQM™ Erectile Quality Monitor are manufactured and distributed by FastSize, LLC of Aliso Viejo, Calif.

28 Jul 2010

News outlets report on medical intellectual property developments, drug access issues

Inter Press Service reports on a recent symposium on access to medicine, "jointly hosted by the WHO, the World Trade Organization and the World Intellectual Property Organisation."

23 Jul 2010

Unapproved cyanide antidote kits seized from Keystone Pharmaceuticals

At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized $39,000 worth of products labeled as cyanide antidote kits from Keystone Pharmaceuticals in Laguna Hills, California. The seizure warrant was issued by the U.S. District Court for the Central District of California.

23 Jul 2010

BDSRA designates Nationwide Children's Hospital as Batten Disease Center of Excellence

Nationwide Children's Hospital has been selected as a Center of Excellence by the Batten Disease Support and Research Association (BDSRA), the largest research and support organization in North America for families that have children with Batten disease. BDSRA chose Nationwide Children's because of its clinical and research history with the disease and its ability to provide comprehensive care for these unique children.

23 Jul 2010

New campaign empowers, inspires women and families affected by epilepsy

A new campaign explores the roles and responsibilities women uniquely encounter when living, or caring for a loved one, with epilepsy. "Women Succeeding with Epilepsy" is a collaboration between Epilepsy Advocate and HealthyWomen to educate, empower and inspire women and families whose lives are affected by epilepsy.

22 Jul 2010

Valproic acid halts vision loss in patients with retinitis pigmentosa

Researchers at the University of Massachusetts Medical School believe they may have found a new treatment for retinitis pigmentosa, a severe neurodegenerative disease of the retina that ultimately results in blindness. One of the more common retinal degenerative diseases, RP is caused by the death of photoreceptor cells and affects 1 in 4,000 people in the United States. RP typically manifests in young adulthood as night blindness or a loss of peripheral vision and in many cases progresses to legal blindness by age 40.

22 Jul 2010

Major turning point in antiepileptic drug testing, development

New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

21 Jul 2010

Traumatic brain injuries during war increase risk of epilepsy even decades later

Soldiers who receive traumatic brain injuries during war may be at a higher risk of epilepsy even decades after the brain injury occurred. The new research is published in the July 20, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

20 Jul 2010

Researchers use bioelectric signals of brain to detect neurodegenerative diseases

A group of researchers from Universidad Carlos III de Madrid has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brain.

20 Jul 2010

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL).

19 Jul 2010

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Meningiomas, the most common type of brain tumors, are rarely cancerous and may not require treatment. The July issue of Mayo Clinic Health Letter offers an overview of this brain tumor that is usually benign.

16 Jul 2010

Professor develops sensor to better regulate fluid flow in hydrocephalus

Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.

16 Jul 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

This week, nearly 4,000 scientists from around the world gathered to report and discuss the latest advances in research on treatments, risk factors, and diagnosis for the health epidemic of the 21st century – Alzheimer's disease – at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease in Honolulu.

15 Jul 2010

Medical standard of care triggers biological responses in brain that can fuel tumor cell survival: Researchers

The medical standard of care - comprised of surgery, radiation and chemotherapy - for the most common form of brain cancer triggers a number of biological responses that may actually feed the energy metabolism that supports the disease, according to Boston College researchers writing in the journal Lancet Oncology.

15 Jul 2010

AD may lead to increased risk of comorbid conditions, research shows

Pfizer Inc., together with its collaborator on the Alzheimer's Immunotherapy Program, Janssen Alzheimer Immunotherapy, presented new research this week at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 from two podium and four poster presentations.

14 Jul 2010

New research shows Alzheimer's disease may increase risk of other potentially disabling health conditions

Having Alzheimer's disease may increase the risk of getting other potentially disabling health conditions, including seizures and anemia, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, HI.

14 Jul 2010

Seizure News and Research

Latest Seizure News and Research

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

Researchers identify new genetic route to treat epilepsy

FDA announces approval of vaccines for 2010-2011 US influenza season

Chemical compound provides new angle for developing drugs to treat seizures: Study

U.S. Marshals seize FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices

News outlets report on medical intellectual property developments, drug access issues

Unapproved cyanide antidote kits seized from Keystone Pharmaceuticals

BDSRA designates Nationwide Children's Hospital as Batten Disease Center of Excellence

New campaign empowers, inspires women and families affected by epilepsy

Valproic acid halts vision loss in patients with retinitis pigmentosa

Major turning point in antiepileptic drug testing, development

Traumatic brain injuries during war increase risk of epilepsy even decades later

Researchers use bioelectric signals of brain to detect neurodegenerative diseases

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Professor develops sensor to better regulate fluid flow in hydrocephalus

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

Medical standard of care triggers biological responses in brain that can fuel tumor cell survival: Researchers

AD may lead to increased risk of comorbid conditions, research shows

New research shows Alzheimer's disease may increase risk of other potentially disabling health conditions

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Seizure News and Research

Latest Seizure News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in